Sofía Braga
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in ⓘ
- Oncology 36
- Cancer Treatment and Pharmacology 14
- HER2/EGFR in Cancer Research 14
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 6
- Cancer Cells and Metastasis 4
-
- Brain Metastases and Treatment 13
- Advanced Breast Cancer Therapies 9
- Co-authors
- M. Guadalupe Cabral (5 shared papers)Diana P. Saraiva (5 shared papers)António Jacinto (5 shared papers)José Luís Passos‐Coelho (3 shared papers)Marta Vaz Batista (16 shared papers)Ahmad Awada (2 shared papers)Martine Piccart (4 shared papers)Paula Borralho (7 shared papers)
In The Last Decade
Sofía Braga
50 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 931
- Cancer Research 357
- Pulmonary and Respiratory Medicine 430
- Genetics 78
- Immunology 150
Countries citing papers authored by Sofía Braga
This map shows the geographic impact of Sofía Braga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofía Braga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofía Braga more than expected).
Fields of papers citing papers by Sofía Braga
This network shows the impact of papers produced by Sofía Braga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofía Braga. The network helps show where Sofía Braga may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofía Braga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 298 | |
| 2 | 2006 | 172 | |
| 3 | Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial Hit paper breakdown → | 2022 | 162 |
| 4 | 2007 | 90 | |
| 5 | 2021 | 85 | |
| 6 | 2020 | 59 | |
| 7 | 2008 | 55 | |
| 8 | 2011 | 52 | |
| 9 | 2018 | 51 | |
| 10 | 2006 | 49 | |
| 11 | 2017 | 46 | |
| 12 | 2017 | 45 | |
| 13 | 2022 | 34 | |
| 14 | 2021 | 33 | |
| 15 | 2021 | 25 | |
| 16 | 2021 | 21 | |
| 17 | 2016 | 17 | |
| 18 | 2024 | 13 | |
| 19 | 2020 | 13 | |
| 20 | 2006 | 13 |
About Sofía Braga
Sofía Braga is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), HER2/EGFR in Cancer Research (14 papers), Brain Metastases and Treatment (13 papers), Advanced Breast Cancer Therapies (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (6 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Oncology (931 citations), Cancer Research (357 citations), Pulmonary and Respiratory Medicine (430 citations), Genetics (78 citations) and Immunology (150 citations). Sofía Braga has collaborated with scholars based in Portugal, Spain and Belgium. Frequent co-authors include M. Guadalupe Cabral, Diana P. Saraiva, António Jacinto, José Luís Passos‐Coelho, Marta Vaz Batista, Ahmad Awada, Martine Piccart, Paula Borralho, Fátima Cardoso and Javier Cortés. Their work appears in journals such as Cancer Research, ESMO Open, Annals of Oncology, Journal of Clinical Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.